HU9503983D0 - Agonists and antagonists of human interleukin-10 - Google Patents

Agonists and antagonists of human interleukin-10

Info

Publication number
HU9503983D0
HU9503983D0 HU9503983A HU9503983A HU9503983D0 HU 9503983 D0 HU9503983 D0 HU 9503983D0 HU 9503983 A HU9503983 A HU 9503983A HU 9503983 A HU9503983 A HU 9503983A HU 9503983 D0 HU9503983 D0 HU 9503983D0
Authority
HU
Hungary
Prior art keywords
agonists
antagonists
human interleukin
interleukin
human
Prior art date
Application number
HU9503983A
Other languages
Hungarian (hu)
Other versions
HUT73463A (en
Inventor
Chuan-Chu Chou
Xia-Yan Cai
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HU9503983D0 publication Critical patent/HU9503983D0/en
Publication of HUT73463A publication Critical patent/HUT73463A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU9503983A 1993-07-26 1994-07-22 Agonists and antagonists of human interleukin-10 HUT73463A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894393A 1993-07-26 1993-07-26

Publications (2)

Publication Number Publication Date
HU9503983D0 true HU9503983D0 (en) 1996-03-28
HUT73463A HUT73463A (en) 1996-08-28

Family

ID=22271670

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503983A HUT73463A (en) 1993-07-26 1994-07-22 Agonists and antagonists of human interleukin-10

Country Status (17)

Country Link
EP (1) EP0711346A1 (en)
JP (1) JPH08507930A (en)
KR (1) KR960704041A (en)
CN (1) CN1127529A (en)
AU (1) AU681178B2 (en)
CA (1) CA2168110A1 (en)
CZ (1) CZ23396A3 (en)
FI (1) FI960353A (en)
HU (1) HUT73463A (en)
IL (1) IL110413A0 (en)
NO (1) NO960309D0 (en)
NZ (1) NZ269663A (en)
PL (1) PL312718A1 (en)
SG (1) SG43798A1 (en)
SK (2) SK150596A3 (en)
WO (1) WO1995003411A1 (en)
ZA (1) ZA945434B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283096B6 (en) 1994-07-05 2003-02-04 Steeno Research Group A/S Immunomodulators
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
WO1997026278A1 (en) 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
DE19851675A1 (en) * 1998-11-10 2000-05-11 Bayer Ag Human interleukin-10 mutant proteins
EP1283722A1 (en) 2000-03-31 2003-02-19 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
ES2367891T3 (en) 2000-09-29 2011-11-10 Schering Corporation INTERLEUCINA-10 PEGILADA.
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
EP1885863B1 (en) 2005-05-31 2014-11-19 The Regents of the University of Colorado, a body corporate Methods for delivering genes
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
WO2010040105A2 (en) 2008-10-02 2010-04-08 Trubion Pharmaceuticals, Inc. Cd86 antagonist multi-target binding proteins
AU2009333325B2 (en) 2008-12-17 2014-07-10 Merck Sharp & Dohme Corp. Mono- and di-peg IL-10 production; and uses
CN108129574A (en) 2011-11-08 2018-06-08 Umc乌德勒支控股有限公司 Fusion protein including interleukin 10 and interleukin-4
JP2016519108A (en) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド Method for using interleukin-10 for the treatment of diseases and disorders
WO2014176373A2 (en) * 2013-04-24 2014-10-30 Armo Biosciences, Inc. Interleukin-10 compositions and uses thereof
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
CN105658232A (en) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 Methods of using interleukin-10 for treating diseases and disorders
ES2862139T3 (en) 2013-11-11 2021-10-07 Armo Biosciences Inc Procedures for the use of Interleukin 10 for the treatment of diseases and disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3206713A4 (en) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
US10143726B2 (en) 2014-10-22 2018-12-04 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
KR20180020141A (en) 2015-05-28 2018-02-27 아르모 바이오사이언시스 인코포레이티드 PEGylated interleukin-10 for cancer treatment
MX2018002298A (en) 2015-08-25 2018-07-06 Armo Biosciences Inc Methods of using interleukin-10 for treating diseases and disorders.
GB2600564B (en) 2019-04-19 2024-02-28 Synerkine Pharma B V A fusion protein comprising IL13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113229A (en) * 1987-10-27 1989-05-01 Inahata Kenkyusho:Kk Porous material of honeycomb structure
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
CA2115060C (en) * 1991-08-06 2003-05-06 Rene De Waal Malefyt Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity

Also Published As

Publication number Publication date
AU681178B2 (en) 1997-08-21
SG43798A1 (en) 1997-11-14
IL110413A0 (en) 1994-10-21
HUT73463A (en) 1996-08-28
WO1995003411A1 (en) 1995-02-02
ZA945434B (en) 1995-01-23
CZ23396A3 (en) 1996-05-15
CA2168110A1 (en) 1995-02-02
CN1127529A (en) 1996-07-24
NO960309L (en) 1996-01-25
FI960353A0 (en) 1996-01-26
NO960309D0 (en) 1996-01-25
SK8396A3 (en) 1997-03-05
PL312718A1 (en) 1996-05-13
AU7399694A (en) 1995-02-20
FI960353A (en) 1996-01-26
JPH08507930A (en) 1996-08-27
NZ269663A (en) 1997-09-22
EP0711346A1 (en) 1996-05-15
SK150596A3 (en) 1997-04-09
KR960704041A (en) 1996-08-31

Similar Documents

Publication Publication Date Title
HU9503983D0 (en) Agonists and antagonists of human interleukin-10
EP0880356A4 (en) Antimicrobial peptides and methods of use
GB9300213D0 (en) Wrist and hand support
IL106732A0 (en) Human interleukin-13
ZA936097B (en) Human interleukin-13
AR243240A1 (en) Human interleukin-3 and muteins thereof
ZA9710979B (en) Novel heterocyclically substituted benzamides and their use
EP0586687A4 (en) Trans-sialidase and methods of use and making thereof
EP0729300A4 (en) Novel fas protein and methods of use thereof
HU9600241D0 (en) Mutable composition and methods of use thereof
EP0445801A3 (en) Peptide and its use
HU9402361D0 (en) New makrolides and use of them
GB9219425D0 (en) Therapeutic agent and its use
AU4596896A (en) Substituted benzamides and radioligand analogs and methods of use
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
GB2294637B (en) Therapeutic compositions and methods of use
HUP9800146A3 (en) Thalidomide-derivatives and use of them
GB8923571D0 (en) Connecting means and method of use thereof
PL307138A1 (en) Amyline antagonists and agonists
EP0540575A4 (en) Human meg-csf protein and methods
KR910007551B1 (en) Polyethylene terephchalate and its use
GB9501907D0 (en) Allatostatins and their use
GB9314512D0 (en) Composition and use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment